FDA’s Easing on Obesity Drugs Could Fatten Investor Wallets – Investorplace.com
|
FDA's Easing on Obesity Drugs Could Fatten Investor Wallets
Investorplace.com based Vivus (NASDAQ:VVUS) and Qnexa, the company's drug candidate being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. Last fall, Qnexa looked like it had about as good a chance of hitting the market as the Tampa Bay … Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss |
View full post on Diet Weight Loss – Google News
Could, drugs, Easing, Fatten, FDA's, Investor, Investorplace.com, obesity, Wallets
